Skip to main content
SpringerLink
Log in
Book cover

Peritoneal Carcinomatosis: Drugs and Diseases pp 227–237Cite as

Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 81))

Abstract

Each year in the United States, approximately 28,000 people develop cancer of the pancreas, resulting in an incidence of 9 cases per 100,000 population [1,2]. Although the incidence of cancers at several other sites is higher, pancreatic carcinoma is the fourth leading cause of cancer death behind malignancies of the lung, prostate, and colorectum in men and cancer of the lung, breast, and colorectum in women [2]. A review of 85 published series encompassing 22,319 patients with pancreatic cancer revealed that only 0.4 percent of patients survived at least 5 years following diagnosis [3].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Warshaw AL, Fernandez-Del Castillo C. Pancreatic carcinoma. N Eng J Med 1992;326:455–465.

    Article  CAS  Google Scholar 

  2. Silverberg E, Lubera JA. Cancer statistics. CA Cancer J 1989;39:3–20.

    Article  CAS  Google Scholar 

  3. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284–2303.

    Article  PubMed  CAS  Google Scholar 

  4. Warshaw AL, Swanson RS. Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg 1988;208:541–553.

    Article  PubMed  CAS  Google Scholar 

  5. Ohta T, Nagakawa T, Ueno K, Kayahara M, Mori K, Kobayashi H, Takeda T, Miyazaki I. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size. Int Surg 1993;78:208–212.

    PubMed  CAS  Google Scholar 

  6. Fortner JG. Regional pancreatictomy for cancer of the pancreas, ampulla, and other related sites. Ann Surg 1984;199:418–425.

    Article  PubMed  CAS  Google Scholar 

  7. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989;124:127–132.

    PubMed  CAS  Google Scholar 

  8. Nagai H, Kuroda A, Morioka Y. Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg 1986;204:65–71.

    Article  PubMed  CAS  Google Scholar 

  9. Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R, Eto T. Collective review of small carcinomas of the pancreas. Ann Surg 1986;203:77–81.

    Article  PubMed  CAS  Google Scholar 

  10. Manabe T, Tobe T. Progress in the diagnosis and treatment of pancreatic cancer—The Kyoto University experience. Hepatogastroenterology 1989;36:431–436.

    PubMed  CAS  Google Scholar 

  11. Arbuck SG. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 1990;7:209–222.

    PubMed  CAS  Google Scholar 

  12. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358–365.

    Article  PubMed  CAS  Google Scholar 

  13. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.

    Article  PubMed  CAS  Google Scholar 

  14. Camerson JL, Crist DW, Sitzman JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120–125.

    Article  Google Scholar 

  15. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68–73.

    Article  PubMed  CAS  Google Scholar 

  16. Tepper J, Nardi G, Suit H. Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973. Cancer 1976;37:1519–1524.

    Article  PubMed  CAS  Google Scholar 

  17. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RES, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56–61.

    Article  PubMed  CAS  Google Scholar 

  18. Mohiuddin M, Cantor RJ, Bierman W, Weiss SM, Barbot D, Rosato FE. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1988;14:79–84.

    Article  PubMed  CAS  Google Scholar 

  19. Warshaw AL, Tepper JE, Shipley WU. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986;151:76–80.

    Article  PubMed  CAS  Google Scholar 

  20. Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26–30.

    Article  PubMed  CAS  Google Scholar 

  21. Billingsley JS, Bartholomeu JG, Childs DS. A study of radiation therapy in carcinoma of the pancreas. Proc Staff Meet Mayo Clinic 1958;33:426.

    CAS  Google Scholar 

  22. Miller TR, Fuller LM. Radiation therapy of carcinoma of the pancreas. Report on 91 cases. Am J Roentgenol Radium There Nucl Med 1958;80:787.

    CAS  Google Scholar 

  23. Haslam JB, Cavanaugh PJ, Stroup SL. Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas. Cancer 1973;32:1341.

    Article  PubMed  CAS  Google Scholar 

  24. Whittington P, Dobelbower RR, Mohiuddin M, Rosato FE, Weiss JM. Radiotherapy of unresectable pancreatic carcinoma: A six year experience with 104 patients. Int J Radiat Oncol Biol Phys 1981;7:1639–1644.

    Article  PubMed  CAS  Google Scholar 

  25. Kaiser MH, Ellenberg SS. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899–903.

    Google Scholar 

  26. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006–2010.

    Article  Google Scholar 

  27. Gastrointestinal Tumor Study Group. A multiinstitutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979;1989:205–208.

    Google Scholar 

  28. Gastrointestinal Tumor Study Group. Tratment of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6,000 rads) radiation alone, moderate dose radiation (4,000 radiation + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705–1710.

    Article  Google Scholar 

  29. Markman M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol Obstet 1987;164:89–93.

    PubMed  CAS  Google Scholar 

  30. Speyer JL. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol 1985;3:23–28.

    Google Scholar 

  31. Markman M, Howell SB. Intraperitoneal chemotherapy: Principles and results of clinical trials. Cancer Treat Res 1987;36:39–59.

    Google Scholar 

  32. Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991;18:248–254.

    PubMed  CAS  Google Scholar 

  33. Speyer JL, Collins JM, Dedrick RL, Brennan M, Buckpitt AR, Londer H, DeVita VT, Myers CE. Phase I and pharmacologic studies of 5-fluorouracil administered intraperitoneally. Cancer Res 1980;40:567–572.

    PubMed  CAS  Google Scholar 

  34. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985;98:414–421.

    PubMed  CAS  Google Scholar 

  35. Lukas G, Brindle SD, Greengard P. The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Therap 1971;178:562–566.

    CAS  Google Scholar 

  36. Taylor I, Bennett R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer 1979;39:749–756.

    Google Scholar 

  37. Speyer JL. Intraperitoneal chemotherapy: A possible role in the treatment of hepatic metastases. Dev Oncol 1985;30:225–235.

    Google Scholar 

  38. Los G, Mutsaers PHA, van der Vijgh WJF, Baldew GS, de Graaf PW, McVie JG. Direct diffusion of cis-diamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: A comparison with systemic chemotherapy. Cancer Res 1989;49:3380–3384.

    PubMed  CAS  Google Scholar 

  39. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–97.

    PubMed  CAS  Google Scholar 

  40. Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989;76:1082–1090.

    Article  PubMed  CAS  Google Scholar 

  41. Goldie JH. Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy. Semin Oncol 1987;14:1–7.

    PubMed  CAS  Google Scholar 

  42. Simpson-Heren L, Sanford AH, Holmquist JP. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 1976;60:1749–1760.

    Google Scholar 

  43. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861–3865.

    PubMed  CAS  Google Scholar 

  44. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488–1492.

    PubMed  CAS  Google Scholar 

  45. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norm T. Surgical adjuvant chemotherapy: Results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 1987;41:2088–2098.

    Article  Google Scholar 

  46. Stanley CJ, Trippet OH, Preston FW. Influence of 5-fluorouracil on wound healing. Surgery 1961;40:450.

    Google Scholar 

  47. Morris T. Retardation of healing of large bowel anastomoses by 5-fluorouracil. Aust N Z J Surg 1979;49:743.

    Article  PubMed  CAS  Google Scholar 

  48. Graf W, Weiber S, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Influence of 5-fluorouracil and folinic acid on colonic healing: An experimental study in the rats. Br J Surg 1992;79:825.

    Article  PubMed  CAS  Google Scholar 

  49. Graf W, Ivarsgon M, Gerdin B, Hellsing K, Pahlman L, Glimelius B. The influence of early postoperative intraperitoneal chemotherapy on human wound healing. J Surg Res 1994;57:394–400.

    Article  PubMed  CAS  Google Scholar 

  50. Sugarbaker PH, Cunliffe WJ, Belliveau J, deBruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–89.

    PubMed  CAS  Google Scholar 

  51. Esquivel J, Vidal-Jove J, Steves MA, Sugarbaker PH. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631–636.

    PubMed  CAS  Google Scholar 

  52. Gerweck LE, Richards B, Jennings M. The influence of variable oxygen concentration on the response of cells to heat or x-irradiation. Radiat Res 1980;85:314–320.

    Article  Google Scholar 

  53. Dewey W, Hopwood L, Sapareto S. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977;123:463–474.

    PubMed  CAS  Google Scholar 

  54. Urano M, Gerweck LE, Epstein R. Response of a spontaneous murine tumor to hyperthermia: Factors which modify the thermal response in viro. Radiat Res 1980;83:312–322.

    Article  PubMed  CAS  Google Scholar 

  55. Dudarte, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605–612.

    Google Scholar 

  56. Reinhold HS, Endlich BA. Tumor microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:111–137.

    Article  PubMed  CAS  Google Scholar 

  57. Hahn GM. Hyperthermia in Cancer. New York: Plenum Press, 1982.

    Google Scholar 

  58. Teicher B, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096–1099.

    PubMed  CAS  Google Scholar 

  59. Zakris EL, Dewhirst NW, Riviere JE, Hooper PJ, Page RL, Oleson JR. Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. J Clin Oncol 1987;5:1613–1620.

    PubMed  CAS  Google Scholar 

  60. Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama H, Osak Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 1984;44:1840–1842.

    PubMed  CAS  Google Scholar 

  61. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Zrimizu N, Takamizawa H. Ann Surg 1988;208:36–41.

    Article  PubMed  CAS  Google Scholar 

  62. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232–237.

    Article  PubMed  CAS  Google Scholar 

  63. Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Okui K. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198–202.

    Google Scholar 

  64. Fijimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasegawa H, Katayama K, Miwa K, Miyazaki I. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.

    Article  Google Scholar 

  65. Fujimoto S, Shrestha RD, Kokubin M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Yk, Mizutani M, Chikenji T, Okui K. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212:592–596.

    Article  PubMed  CAS  Google Scholar 

  66. Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutoh T, Ohkubo H. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992;70:2754–2760.

    Article  PubMed  CAS  Google Scholar 

  67. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer: Final results of a randomized control study Cancer 1994;73:2048–2052.

    Article  PubMed  CAS  Google Scholar 

  68. Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichloradimmineplatinum (11) and mitomycin C. Cancer Res 1980;40:1165–1168.

    PubMed  CAS  Google Scholar 

  69. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530–536.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Stephen E. Ettinghausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew M. Averbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington Cancer Institute, Washington Hospital Center, 110 Irving Street, NW, Washington, D.C., 20010, USA

    Paul H. Sugarbaker M.D., F.A.C.S.

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Ettinghausen, S.E., Averbach, A.M. (1996). Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Drugs and Diseases. Cancer Treatment and Research, vol 81. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1245-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1245-1_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-7923-3726-3

  • Online ISBN: 978-1-4613-1245-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation